Point72 Asset Management
AGN

Point72 Asset Management’s Allergan plc AGN Stock Holding History

Point72 Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,500
Closed -$2.61M – 1372
2019
Q3 		$2.61M Buy
+15,500
New +$2.53M 0.02% 558

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management's AGN Position: Q3 2019 in Review

Point72 Asset Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 25,000 shares — an estimated $4.07M sold.

Point72 Asset Management first reported a position in AGN in Q2 2014 and held it in 13 quarters. The position peaked at $92.2M in Q3 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Point72 Asset Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Point72 Asset Management sold 25,000 Allergan plc shares in Q3 2019, an estimated $4.07M.
  • Point72 Asset Management first reported a position in Allergan plc in Q2 2014 and held it in 13 quarters.
  • Point72 Asset Management's Allergan plc position peaked at $92.2M in Q3 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Point72 Asset Management's 13F filing for Q3 2019, filed 15 Nov 2019.